Last reviewed · How we verify
Hyaluronic Acid Injection
Hyaluronic Acid Injection is a Viscosupplement Small molecule drug developed by Wroclaw Medical University. It is currently FDA-approved for Osteoarthritis of the knee, Joint pain and dysfunction. Also known as: HA, gengigel, Reviscon Mono, Oddent.
Hyaluronic acid acts as a viscoelastic agent that lubricates and cushions joints by mimicking the properties of natural synovial fluid.
Hyaluronic acid acts as a viscoelastic agent that lubricates and cushions joints by mimicking the properties of natural synovial fluid. Used for Osteoarthritis of the knee, Joint pain and dysfunction.
At a glance
| Generic name | Hyaluronic Acid Injection |
|---|---|
| Also known as | HA, gengigel, Reviscon Mono, Oddent, Restylane |
| Sponsor | Wroclaw Medical University |
| Drug class | Viscosupplement |
| Modality | Small molecule |
| Therapeutic area | Rheumatology / Orthopedics |
| Phase | FDA-approved |
Mechanism of action
Hyaluronic acid is a naturally occurring polysaccharide found in synovial fluid that provides viscosity and elasticity to joints. When injected intra-articularly, it reduces friction between cartilage surfaces, absorbs shock, and may have anti-inflammatory properties. This mechanical lubrication and potential biological effects help alleviate pain and improve joint function in osteoarthritis.
Approved indications
- Osteoarthritis of the knee
- Joint pain and dysfunction
Common side effects
- Injection site pain or swelling
- Transient joint effusion
- Local inflammation
Key clinical trials
- Clinical Investigation on Lips Treated With HA-filler (NA)
- A Post-market-clinical Follow-up Investigation of Safety and Performance by Decoria® Voluma (NA)
- The Efficacy and Safety of a Single-Dose Hyaluronic Acid Injection in the Treatment of Knee Osteoarthritis
- XVIE to Treat Androgenetic Alopecia (AGA) (PHASE1, PHASE2)
- Efficacy and Safety of Vaginal Radiofrequency for Vulvovaginal Atrophy in Breast Cancer Patients (NA)
- Efficacy of Therapy With PRP Injections Versus HA in Patients With Advanced Grade of GONArthrosis (NA)
- Comparison of Hyaluronic Acid, Injectable Platelet-Rich Fibrin, and Prolotherapy in TMJ Arthrocentesis (NA)
- Hyaluronic Acid Injection in Idiopathic Carpal Tunnel Syndrome; is it Effective as Local Corticosteroids (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Hyaluronic Acid Injection CI brief — competitive landscape report
- Hyaluronic Acid Injection updates RSS · CI watch RSS
- Wroclaw Medical University portfolio CI
Frequently asked questions about Hyaluronic Acid Injection
What is Hyaluronic Acid Injection?
How does Hyaluronic Acid Injection work?
What is Hyaluronic Acid Injection used for?
Who makes Hyaluronic Acid Injection?
Is Hyaluronic Acid Injection also known as anything else?
What drug class is Hyaluronic Acid Injection in?
What development phase is Hyaluronic Acid Injection in?
What are the side effects of Hyaluronic Acid Injection?
Related
- Drug class: All Viscosupplement drugs
- Manufacturer: Wroclaw Medical University — full pipeline
- Therapeutic area: All drugs in Rheumatology / Orthopedics
- Indication: Drugs for Osteoarthritis of the knee
- Indication: Drugs for Joint pain and dysfunction
- Also known as: HA, gengigel, Reviscon Mono, Oddent, Restylane
- Compare: Hyaluronic Acid Injection vs similar drugs
- Pricing: Hyaluronic Acid Injection cost, discount & access